Histamine plays a complex role in cancer development in dogs, particularly in the context of mast cell tumors (MCTs). Histamine is a biogenic amine and critical chemical mediator that plays a pivotal role in many physiological responses in dogs. The compound is synthesized from the essential amino acid histidine and is predominantly stored in mast cells and basophils, integral immune system components.

Located throughout the body in almost all tissues, mast cells and basophils release histamine in response to stressors such as allergens or physical injuries. Mast cells, normal and neoplastic, contain and release essential biologically active substances: heparin, histamine, eosinophilic chemotactic factor, and proteolytic enzymes. 

Upon release, histamine induces vasodilation, the widening of blood vessels, facilitating the rapid mobilization and distribution of immune cells, including mast cells and basophils, to sites of inflammation or injury. This mechanism is crucial for initiating the body's defense processes and is central to dogs' immune response and inflammation management.

Mast cells are an essential type of white blood cell that plays a crucial role in a dog's immune system. They are part of the body's defense mechanism, primarily in allergic reactions and inflammation responses. Mast cells are found throughout the body but are most commonly located in tissues that interface with the external environment, such as the skin, lungs, and digestive tract. This strategic placement allows them to effectively respond to external threats such as allergens, pathogens, and physical injuries.

Mast cells contain granules that are filled with various chemical mediators, including:

Histamine: A compound that increases the permeability of the capillaries to white blood cells and some proteins to allow them to engage pathogens in the infected tissues. Histamine is responsible for many clinical signs of allergic reactions, such as redness, swelling, and itching.

Heparin: An anticoagulant that prevents blood clotting, vital in areas of inflammation or injury to maintain blood flow.

Cytokines and Chemokines: These proteins signal and recruit other immune cells to areas needed to respond to infection or injury.

Mast cells are integral to allergic responses. When an allergen enters the body, it can bind to antibodies on the surface of mast cells. This binding triggers the mast cells to release their granules into the surrounding tissues, a process known as degranulation. The chemicals released lead to the clinical signs associated with allergies, such as itching, hives, and respiratory issues.

Beyond allergies, mast cells play a broader role in inflammation. Allergens, physical injuries, and infections can activate them. Upon activation, they release substances that can either promote or modulate inflammation, depending on the signals they receive from other parts of the immune system.

The Transformation of Mast Cells to Mast Cell Tumors

While mast cells are beneficial for health, they can sometimes form tumors, known as mast cell tumors (MCTs), among the most common cancers in dogs. These tumors can vary widely in their behavior, from benign growths that may not require extensive treatment to aggressive malignant tumors that can spread to other parts of the body.

MCTs can vary widely in appearance and occur almost anywhere on the body, although they are most commonly found on the skin. The tumors may be seen as solitary lumps or masses on the skin, which can be occasionally itchy or irritating to the dog.

The behavior of MCTs can range from relatively benign to highly aggressive:

Grade I tumors are generally considered benign and often curable with complete surgical removal.

Grade II tumors are intermediate and can be unpredictable. They may not spread extensively but can be locally invasive.

Grade III tumors are considered malignant and aggressive, often spreading to other parts of the body, including the lymph nodes, spleen, liver, and bone marrow.

Diagnosis of mast cell tumors typically involves fine needle aspiration or biopsy, where cells from the tumor are examined microscopically. All lumps and bumps should be noted, observed often, and biopsied if they grow or become ulcerated. Lipomas, a typically benign tumor, can mask a mast cell tumor within it; some mast cell tumors greatly resemble lipomas. Additional tests, such as ultrasound, X-rays, or blood tests, may be necessary to determine if the cancer has spread (metastasized) to other body parts.

Research has identified genetic factors associated with the development of MCTs in dogs, including mutations in the c-kit gene, which can affect the behavior of the tumors and influence treatment responses. Understanding these genetic components can help in developing more effective, targeted therapies.

Certain dog breeds are known to be predisposed to developing mast cell tumors (MCTs), suggesting a genetic component to their risk. Predisposed breeds include Boxers, Labrador retrievers, Golden retrievers, French bulldogs, Staffordshire bull terriers, Shar-Peis, American Staffordshire Terriers, Boston Terriers, Pugs, and English Springer Spaniels. 

Multiple studies have identified these breeds, highlighting the importance of genetic factors in developing mast cell tumors in dogs. Owners of these breeds should regularly check their dogs for any signs of tumors and seek veterinary advice promptly if any abnormalities are found.

Mast cell tumors (MCTs) are a common type of cancer in dogs, representing a significant percentage of all skin tumors found in canines. These tumors arise from mast cells, white blood cells crucial to the body's allergic responses and inflammation.

Histamine is synthesized and stored in mast cells. High histamine levels and its synthesizing enzyme, histidine decarboxylase, have been found in growing experimental tumors. Treatment with specific inhibitors of histidine decarboxylase can markedly reduce tumor growth, suggesting that newly synthesized histamine plays a significant role in the tumor development process.

Histamine has been shown to suppress the host immune system by activating histamine H2 receptors on suppressor lymphocytes, which can further facilitate tumor growth. Elevated plasma histamine concentrations (PHCs) have been closely associated with disease progression in dogs with mast cell tumors (MCTs). Studies have shown that dogs with higher PHCs tend to exhibit more aggressive disease and poorer outcomes. Additionally, elevated histamine levels can lead to gastrointestinal complications common in dogs with MCTs, such as ulceration, due to increased gastric acidity stimulated by histamine. 

The findings in studies underscore the importance of histamine in both the progression and potential treatment of mast cell tumors in dogs, suggesting that modulation of histamine levels and its receptor interactions could be a viable strategy in managing these cancers.

Histamine plays a significant role in the pathology of mast cell tumors (MCTs) in dogs, primarily due to its elevated levels in affected animals, which can lead to several complications. Dogs with mast cell tumors often exhibit elevated plasma histamine levels, which can lead to gastrointestinal ulceration. Hyperhistaminemia induces increased gastric acidity, which in turn leads to ulcer formation. Studies have shown that plasma histamine concentrations in dogs with MCTs are significantly higher than in healthy dogs.

Further research indicates that plasma histamine concentrations (PHCs) can be associated with disease progression in dogs with MCTs. Dogs with grossly visible disease tend to have higher initial PHCs compared to those with microscopic disease, and there's a noted correlation between rising PHC levels and worsening of the disease. Additionally, high PHCs are linked to gastrointestinal signs that are refractory to histamine-2 (H-2) blocker therapy, underscoring the impact of histamine on MCT-related morbidity.

Treatment varies based on the tumor's location, grade, and stage. Surgical removal is standard for localized tumors, but higher-grade or metastatic tumors may require additional treatments such as chemotherapy, radiation, or targeted therapies. Newer treatments include tyrosine kinase inhibitors, which target specific molecular pathways involved in the growth and survival of mast cell tumors. 

General holistic health practices can contribute to overall well-being. They may reduce the risk of various cancers, including mast cell tumors. A balanced, nutritious diet appropriate for the dog's age, weight, and health conditions can help maintain overall health and support immune function. Incorporating fresh, whole foods and minimizing processed foods may help reduce exposure to potential carcinogens.

Some nutrient-based approaches have been explored to prevent and manage mast cell tumors in dogs. A notable study that delves into using a specific dietary strategy highlighted the potential of ketogenic metabolic therapy (KMT) as a non-toxic nutritional intervention for managing canine mast cell tumors. The case of a 7-year-old Pit Bull terrier diagnosed with a cutaneous mast cell tumor highlighted the therapeutic use of the KMT. The dog's owner opted for a non-conventional treatment route due to the undesirable side effects associated with standard-of-care treatments.

Initially, the dog was fed a diet of raw vegetables and cooked fish, during which the tumor continued to grow. The diet was then switched to a carbohydrate-free, calorie-restricted ketogenic diet consisting primarily of chicken and oils. Calories were reduced to 60% of the original intake using a dog food calculator. The tumor gradually disappeared over several months following the diet change. The dog maintained a healthy weight and active behavior throughout the dietary intervention. The dog eventually passed away due to heart-related issues at the age of 15, with no recurrence of the mast cell tumor. 

In this case, the resolution of the mast cell tumor was attributed to the diet-induced energy stress and the restriction of glucose, which is essential for the growth of most malignant tumors. This case suggests that a ketogenic diet could effectively manage other canine patients with malignant mast cell tumors by limiting the energy supply (glucose) that fuels tumor growth.

Regular physical activity helps dogs maintain a healthy weight, improves cardiovascular health, and boosts overall immune function, potentially reducing cancer risk. Reducing stress through regular exercise and play and ensuring a comfortable living environment can support the immune system and overall health.

Dog parents must minimize exposure to known carcinogens, such as certain pesticides, herbicides, and household chemicals, is crucial. Using natural, pet-safe products can reduce risk factors associated with environmental toxins.

Dog parents should have their hands on their dogs as often as possible. Routine grooming and petting can reveal small growths in the very early stages, allowing for the safe removal of the growth before it becomes unmanageable. Routine veterinary check-ups also aid in the early detection of MCTs. Early detection and management of MCTs can significantly improve outcomes.

While these practices are generally suitable for overall health, they are not guaranteed to prevent mast cell tumors specifically. The effectiveness of holistic prevention methods can vary greatly depending on individual factors in each dog, including genetics and environmental exposures. 

Low Histamine and Ketogenic Diets For Dogs Mast Cell Tumors

The complex role of histamine in MCTs in dogs underscores the importance of managing histamine levels as part of the therapeutic strategy to alleviate clinical signs and potentially influence the course of the disease.

Low histamine diets for dogs aim to reduce the intake of foods high in histamine or that trigger histamine release. The histamine contents of food vary significantly: for example, freshly caught fish contain almost no histamine, while cured, pickled, or not-so-fresh fish can contain more than 2,000 mg/kg of histamine. Cheese is another food that has significant variation in the concentration of histamine. In general, foods to avoid when wanting to restrict the consumption of histamine are:

Fermented dairy products - cheese (especially aged), yogurt, sour cream, buttermilk, and kefir

Fermented vegetables - sauerkraut and kimchi

Cured or fermented meats- sausages, salami, and ham

Frozen, salted, or canned fish-salmon, sardines, and tuna

Food cooked for extended periods, such as bone broth 

A study on the histamine content in plant-origin foods noted that while some plant foods like eggplant, spinach, tomato, and avocado contain significant histamine levels, many others do not. The study also mentioned that histamine levels can vary significantly depending on the food's origin and how it is stored or processed. This suggests that not all plant foods must be excluded from a low histamine diet. This information could help more accurately define which foods to avoid or limit in dogs' diets with MCTs.

Several dietary supplements can diminish the effects of the histamine response. Omega-3 fatty acids, antioxidants such as vitamins C and E, and other immune-supporting supplements like turmeric help reduce inflammation and support overall cellular health.

Quercetin is a flavonoid that reduces the release of histamine. Nettle is used as a tea or tincture that blocks the activity of histamine. Bromelain is an enzyme found in pineapples and is often supplemented with quercetin for antihistamine effects. Vitamin C supports the detoxification of histamine, while vitamins B6, folate, and B12 all support detoxifying histamine processes.

Feeding a ketogenic diet is essential for dogs with cancer. Dogs often enter ketosis using an 82% fat, 17% protein, and 1% carbohydrate ratio. After 120 days, dogs can have ketosis on a lower formulation (69% fat/30% protein/1% carbs), allowing for higher protein consumption. However, each dog is different. 

The fundamentals of a ketogenic diet are straightforward. The majority of the calories in the diet come from animal fats. Foods such as coconut oil and whole, oily fish can be used as fat sources. Use meats naturally high in fats, such as lamb and pork, as a general guideline. Choosing cuts with more fat will help develop the proper ketogenic diet.

Aim for 90-95% high-fat meat and 5-10% green vegetable matter for dogs, with a maximum of 5% complex carbohydrates. Most meat will not meet the 20-30% fat content because they are leaner cuts. Fatty meat cuts include pork belly, pork shoulder flap, pork butt, pork jowls, beef ribeye, beef short ribs, and chicken thighs. 

The Role of Histamine in Dog Cancers

Feed Real Institute

Services

Summit

We help with